Bio-deactivation of anti-nutritional factors

verified 7 Jul 2026 valid until confidence HIGH 23 sources
efsa fda moa-china

01Overview and value chain

Markers: [EC: EU feed additive authorization (Regulation (EC) 1831/2003) | OECD: Food systems | Regulator: EFSA (EU), FDA (USA), MARA (China)]

Bio-deactivation of anti-nutritional factors (ANFs) applies enzymes and controlled fermentation to neutralize the phytic acid, trypsin inhibitors, β-conglycinin and oligosaccharides naturally present in soy, legume and cereal-based feed and food ingredients, which otherwise bind minerals and amino acids or interfere with digestion. In the EU, DSM-Firmenich received EU authorization on 24 September 2024 for HiPhorius, a next-generation phytase for all poultry species, Suidae (pigs and sows) and fin fish, achieving faster and more complete phytate degradation than earlier-generation phytases. Also in the EU, Denmark’s Hamlet Protein produces specialty fermented soy-based protein ingredients that hold ANF levels — trypsin inhibitors, β-conglycinin, galacto-oligosaccharides — consistently low batch to batch regardless of raw-material variability, and was acquired by Royal Agrifirm Group in a deal completed in May 2026. In China, Vland Biotech’s feed-grade phytase degrades phytate-bound phosphorus in plant-based feed ingredients, cutting livestock and poultry manure phosphorus excretion by 30–60% while releasing bound minerals, amino acids and trace elements for absorption. In the US, Novus International has published a decade-plus data review flagging trypsin inhibitors as a more significant, underappreciated risk in soy-based poultry and swine diets than previously recognized — even after conventional heat processing — and is pairing protease-enzyme supplementation with near-infrared (NIR) testing for more frequent raw-material screening.

The key directions of bio-deactivation of anti-nutritional factors are:

  1. Phytase-mediated phytate degradation (Phytase-Mediated Phytate Degradation): enzymes hydrolyzing phytic acid to release bound phosphorus, minerals and amino acids, cutting manure phosphorus and inorganic phosphate supplementation.
  2. Fermentation-based trypsin-inhibitor and oligosaccharide removal (Fermentation-Based Trypsin-Inhibitor and Oligosaccharide Removal): controlled microbial fermentation of soy/legume meal degrading protease inhibitors and oligosaccharides for young-animal digestibility.
  3. Protease-mediated trypsin-inhibitor neutralization (Protease-Mediated Trypsin-Inhibitor Neutralization): feed enzyme blends breaking down residual trypsin inhibitors that survive conventional heat processing.
  4. Rapid ANF quality screening (Rapid ANF Quality Screening): near-infrared and other rapid analytical technologies for real-time assessment of raw-material ANF variability, replacing infrequent lab testing.

Sectoral value chain

Value chain levels

LevelDescriptionKey inputs/outputs
Raw Material Intakereceiving soy, legume or cereal meal carrying naturally variable ANF contentIn: raw plant-based feed/food ingredient.
Out: batch pending ANF assessment.
ANF Profiling/Screeningrapidly assessing phytate, trypsin-inhibitor or oligosaccharide content of the incoming batchIn: raw batch, NIR/analytical testing.
Out: batch-specific ANF profile.
Bio-Deactivation Treatmentapplying phytase/protease enzymes or controlled fermentation to neutralize the profiled ANFsIn: ANF profile, enzyme/microbial culture.
Out: ANF-reduced ingredient.
Nutrient-Release Verificationconfirming the phosphorus, mineral or amino-acid release achieved by treatmentIn: treated ingredient.
Out: verified nutrient-release/digestibility metric.
Feed/Ingredient Formulationincorporating the verified, ANF-reduced ingredient into a finished feed or food formulationIn: ANF-reduced ingredient.
Out: finished feed/food formulation.
Animal Performance/Salemeasuring growth/digestibility outcomes and selling the finished, ANF-managed formulationIn: finished formulation.
Out: growth performance data, product sale.

Cross-cutting technologies of the sector:

  • Microbial phytase enzymology (Microbial Phytase Enzymology): Aspergillus- and E. coli-derived phytases that hydrolyze phytic acid’s phosphate esters to release bound phosphorus and minerals.
  • Controlled fermentation of legume meal (Controlled Fermentation of Legume Meal): defined fermentation processes degrading trypsin inhibitors, β-conglycinin and galacto-oligosaccharides in soy/legume ingredients.
  • Rapid NIR-based ANF analytics (Rapid NIR-Based ANF Analytics): near-infrared testing enabling frequent, batch-level screening of raw-material ANF variability in place of infrequent lab assays.

02US

The US contributes an awareness and rapid-testing layer to ANF management, led by a feed-additive originator flagging a long-underestimated risk rather than a phytase-manufacturing base.

trypsin-inhibitor awareness research, NIR rapid-testing push, protease-based mitigation

  • Novus International: published a decade-plus data review concluding trypsin inhibitors in soybean meal have a more significant impact on protein digestion and amino-acid availability than previously recognized, even after conventional heat processing, and is promoting protease-enzyme supplementation paired with near-infrared (NIR) testing for more frequent raw-material screening than traditional lab methods allow.

03CN

China anchors large-scale industrial phytase manufacturing aimed at cutting the phosphorus load that plant-based feed’s phytic acid content otherwise sends into livestock manure.

phytase-mediated phosphorus release, manure phosphorus reduction, listed industrial-enzyme scale

  • Vland Biotech: produces a feed-grade phytase that degrades phytate-bound phosphorus in plant-based feed ingredients, releasing bound minerals, amino acids and trace elements for absorption while cutting livestock and poultry manure phosphorus excretion by 30–60%.

04EU

The EU anchors both next-generation phytase enzyme authorization and a distinct fermentation-based approach targeting non-phytate ANFs in soy, now consolidating under strategic (rather than private-equity) feed- industry ownership.

next-generation EU-authorized phytase, fermentation-based soy ANF removal, private-equity-to-strategic ownership shift

  • DSM-Firmenich: received EU authorization on 24 September 2024 for HiPhorius, a next-generation phytase for all poultry species, Suidae and fin fish, achieving faster, more complete phytate degradation than earlier-generation phytases and reducing reliance on inorganic phosphorus supplements.
  • Hamlet Protein: produces specialty fermented soy-based protein ingredients holding trypsin-inhibitor, β-conglycinin and galacto-oligosaccharide levels consistently low batch to batch for young-animal diets; acquired by Royal Agrifirm Group in a deal completed May 2026, moving from private-equity to strategic ownership within Agrifirm’s Specialties division.

05Leading companies and research institutes

Company / InstituteCountryKey products / platformsTech featuresStatus 2026
DSM-Firmenich🇨🇭 SwitzerlandHiPhorius next-generation phytaseEU-authorized 24 Sep 2024; poultry, Suidae, fin fishCommercial
Hamlet Protein🇩🇰 DenmarkFermented soy protein ingredientsconsistently low ANFs (trypsin inhibitor, β-conglycinin, GOS) batch-to-batchCommercial
Vland Biotech🇨🇳 ChinaFeed-grade phytase−30 to −60% manure phosphorus excretionCommercial
Novus International🇺🇸 USATrypsin-inhibitor testing & protease programNIR rapid ANF screening + protease mitigationCommercial

06Tech stack and innovations

The stack pairs enzymatic and fermentation-based deactivation with rapid analytical screening.

  1. Phytase enzymology (Phytase Enzymology):
    • microbial phytases hydrolyze phytic acid’s phosphate esters, releasing bound phosphorus, minerals and amino acids that would otherwise pass through the animal unabsorbed.
    • case: DSM-Firmenich’s HiPhorius achieves faster, more complete phytate degradation than earlier-generation phytases, EU-authorized for poultry, pigs and fin fish.
  2. Fermentation-based ANF reduction (Fermentation-Based ANF Reduction):
    • controlled microbial fermentation of soybean/legume meal degrades trypsin inhibitors, β-conglycinin and galacto-oligosaccharides that survive conventional heat processing.
    • case: Hamlet Protein’s process holds ANF levels consistently low batch to batch regardless of raw-material variability.
  3. Rapid ANF analytics (Rapid ANF Analytics):
    • near-infrared (NIR) and similar rapid-testing technologies screen incoming raw materials for ANF variability far more frequently than traditional lab assays allow.
    • case: Novus International pairs protease supplementation with NIR testing to catch trypsin-inhibitor variability that traditional testing methods miss.

07Value chains and production pipelines

Industrial pipeline of enzymatic/fermentation ANF deactivation (EU Regulation (EC) 1831/2003 feed-additive framework)

Stage 1: Raw material intake

Soy, legume or cereal-based feed/food ingredient arrives carrying naturally variable levels of phytate, trypsin inhibitors or oligosaccharides.

Stage 2: ANF profiling/screening

Near-infrared or other rapid analytical testing assesses the batch’s specific ANF content, replacing infrequent traditional lab assays.

Stage 3: Bio-deactivation treatment

Phytase or protease enzymes, or a controlled fermentation process, are applied to neutralize the profiled anti-nutritional factors.

Stage 4: Nutrient-release verification

The phosphorus, mineral or amino-acid release achieved by the treatment is confirmed against the pre-treatment baseline.

Stage 5: Feed/ingredient formulation

The verified, ANF-reduced ingredient is incorporated into a finished feed or food formulation.

Stage 6: Animal performance/sale

Growth, digestibility and manure-phosphorus outcomes are measured, and the finished ANF-managed formulation is sold.

SupplierPriceCertificatesRiskConfidence
Vland Biotechon requestLowMEDIUM
Novus Internationalon requestMediumMEDIUM
AI Recommendation

AI note: bio-deactivation-anti-nutritional-factors (EN)

Key directions:

  1. Phytase-mediated phytate degradation — enzymes releasing bound phosphorus, minerals and amino acids from phytic acid, cutting manure phosphorus and inorganic phosphate supplementation.
  2. Fermentation-based trypsin-inhibitor and oligosaccharide removal — controlled microbial fermentation of soy/legume meal for young-animal digestibility.
  3. Protease-mediated trypsin-inhibitor neutralization — feed enzyme blends breaking down residual inhibitors that survive conventional heat processing.
  4. Rapid ANF quality screening — near-infrared and similar rapid analytics replacing infrequent lab testing.

Regulatory:

  • EU: DSM-Firmenich’s HiPhorius phytase went through the EU feed-additive authorization pathway (Regulation (EC) 1831/2003), granted 24 September 2024.
  • China: MARA (Ministry of Agriculture and Rural Affairs) frames domestic feed-additive registration and the manure-phosphorus reduction policy driving phytase adoption.

Companies not in table: Alltech, Advanced Enzyme Technologies, Biomin and Sunson Industry Group were all investigated but excluded — Alltech’s and Advanced Enzyme Technologies’ returned sources were generic solid-state-fermentation/phytase academic papers with no attribution to the company’s own confirmed activity; Biomin’s sources were a mix of an unrelated competitor’s product page, a paywalled market report and generic broiler-trial literature; Sunson Industry Group’s Chinese-language sources were marketplace listings and an unrelated agricultural-university lecture announcement, not confirmed company activity. A first India candidate (Advanced Enzyme Technologies) and a second (Biomin) both failed re-verification within the cap-2-per-region rule, so the India/general section stays unconfirmed rather than forcing a third search round.

Processing note: this is a cold-start Industry (no INBOX dossier seed) built with deliberate awareness of a potential MECE collision — industrial-enzymes-biocatalysis already features AB Enzymes’ Monophyx/Zhutase phytase blend and cites Sunson/Angel Yeast as Chinese phytase producers via solid-state fermentation. This article was scoped to stay distinct by (a) using different flagship entities (DSM-Firmenich’s HiPhorius, Vland Biotech, rather than re-using AB Enzymes or Sunson as the lead phytase story) and (b) covering the non-phytate ANF mechanism (fermentation-based trypsin-inhibitor/oligosaccharide removal via Hamlet Protein, plus Novus International’s testing-and-awareness angle) that the sibling enzyme-industry article does not cover at all. Two entities used here (dsm-firmenich, novus-international, vland-biotech) already exist in the graph from other articles with different product lines (DSM’s HMO/vitamins/flavor lines, Novus’s MINTREX trace-mineral chelates, Vland’s broader industrial-enzyme/agri-microbial business) — reused legitimately here for a distinct, source-confirmed product angle (phytase/ANF), not duplicated as new entity stubs.

Relevance: this article’s four entries span the two genuinely distinct bio-deactivation mechanisms — enzymatic phytate hydrolysis (DSM-Firmenich’s newly EU-authorized HiPhorius, Vland Biotech’s high-volume Chinese manufacturing) versus fermentation-based removal of non-phytate ANFs (Hamlet Protein’s specialty soy line, recently absorbed into a major feed group via M&A) — plus a US entity (Novus International) contributing the awareness/testing layer rather than a product, illustrating that the industry’s frontier is as much about detecting ANF variability as neutralizing it.

Compliance Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.